|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 31/69 | (2013.01) | ||
| A61K 38/07 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 47/54 | (2017.01) | ||
| G01N 33/574 | (2013.01) | ||
| A61K 31/69 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 5/0806 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| C07K 5/081 | (2013.01) | ||
| C07K 5/087 | (2006.01) | ||
| C07K 5/0812 | (2013.01) | ||
| C07K 5/062 | (2006.01) | ||
| C07K 5/0821 | (2013.01) | ||
| C07K 5/083 | (2006.01) | ||
| C07K 5/1016 | (2013.01) | ||
| C07K 5/097 | (2006.01) | ||
| C07K 5/0808 | (2013.01) | ||
| C07K 5/107 | (2006.01) | ||
| C07K 5/06078 | (2013.01) | ||
| C07K 5/065 | (2006.01) | ||
| C07K 5/06034 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| C07K 5/06026 | (2013.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61K 47/54 | (2017.08) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 38/07 | (2013.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 2753334 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12827686.2 |
| Date of filing the European patent application | 2012-08-30 | |
| (97) | Date of publication of the European application | 2014-07-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/053140 |
| Date | 2012-08-30 |
| (87) | Number | WO 2013/033396 |
| Date | 2013-03-07 |
| (30) | Number | Date | Country code |
| 201161528824 P | 2011-08-30 | US |
| (72) |
BACHOVCHIN, William, W. , US
LAI, Hung-Sen , US
POPLAWSKI, Sarah, E. , US
|
| (73) |
Trustees of Tufts College ,
136 Harrison Avenue, Boston, MA 02111,
US
|
| (54) | FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS |
| FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS |